Brian Mullan

Chief Technical Officer, Cell and Gene Therapies, Yposkesi

Brian is Head of Innovation, Analytical and Process Development, Cell and Gene Therapies at Yposkesi, where he leads analytical and process development activities, process industrialisation and technological innovation.

Yposkesi is a leading CDMO focused on the development and production of gene therapy vectors (AAV, Lentivirus) for human use, and is based in the Corbeil-Essonnes (south of Paris), France.

Brian has wide experience in process development, product management and commericalisation of biologics, having previously worked for Janssen Biologics, Eli Lilly and Novartis.

Prior to joining Yposkesi, he was Head, Manufacturing Science and Technology for a Novartis biologics manufacturing site. He holds a degree in Biochemistry, a PhD in Viral Genetics, and an MBA.

Leonardo Royal Hotel London Tower Bridge

20 October 2022